GB1455116A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1455116A
GB1455116A GB4347873A GB4347873A GB1455116A GB 1455116 A GB1455116 A GB 1455116A GB 4347873 A GB4347873 A GB 4347873A GB 4347873 A GB4347873 A GB 4347873A GB 1455116 A GB1455116 A GB 1455116A
Authority
GB
United Kingdom
Prior art keywords
radical
carbon atoms
stands
hydrogen
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4347873A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RYLOXYALKANOLAMINE DERIVATIVES
Imperial Chemical Industries Ltd
Original Assignee
RYLOXYALKANOLAMINE DERIVATIVES
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RYLOXYALKANOLAMINE DERIVATIVES, Imperial Chemical Industries Ltd filed Critical RYLOXYALKANOLAMINE DERIVATIVES
Priority to GB4347873A priority Critical patent/GB1455116A/en
Priority to IE2183/73A priority patent/IE38602B1/xx
Priority to CA187,289A priority patent/CA1031362A/en
Priority to US421669A priority patent/US3928412A/en
Priority to IN2664/CAL/73A priority patent/IN139418B/en
Priority to IL43795A priority patent/IL43795A/xx
Priority to FI3789/73A priority patent/FI61027C/fi
Priority to GB5751773A priority patent/GB1457876A/en
Priority to SE7316863A priority patent/SE408794B/sv
Priority to LU68997A priority patent/LU68997A1/xx
Priority to NLAANVRAGE7317096,A priority patent/NL179203C/xx
Priority to CH1340177A priority patent/CH605667A5/xx
Priority to YU3246/73A priority patent/YU40097B/xx
Priority to CH1759473A priority patent/CH605666A5/xx
Priority to FR7344780A priority patent/FR2210407B1/fr
Priority to SU7301981054A priority patent/SU576917A3/ru
Priority to AR251531A priority patent/AR213930A1/es
Priority to HUIE600A priority patent/HU169087B/hu
Priority to DK681673A priority patent/DK158466C/da
Priority to CH1340377A priority patent/CH611876A5/xx
Priority to NO4794/73A priority patent/NO138335C/no
Priority to BE138894A priority patent/BE808666A/xx
Priority to DD175410A priority patent/DD113349A5/xx
Priority to CH1340277A priority patent/CH605668A5/xx
Priority to JP48141162A priority patent/JPS5919090B2/ja
Priority to ES421538A priority patent/ES421538A1/es
Priority to CS738727A priority patent/CS187389B2/cs
Priority to AT581577A priority patent/AT345791B/de
Priority to DE2362568A priority patent/DE2362568C2/de
Priority to PL16765273A priority patent/PL94580B1/pl
Priority to SE7407702A priority patent/SE417198B/xx
Priority to LU71449A priority patent/LU71449A1/xx
Priority to NL7416114A priority patent/NL7416114A/xx
Priority to FR7441011A priority patent/FR2254325B2/fr
Priority to DE19742458908 priority patent/DE2458908C2/de
Priority to CH1657074A priority patent/CH614925A5/xx
Priority to US05/607,995 priority patent/US4010189A/en
Priority to GB5003975A priority patent/GB1550838A/en
Priority to AT266376A priority patent/AT344144B/de
Priority to AT266276A priority patent/AT345789B/de
Priority to AR262359A priority patent/AR214288A1/es
Priority to US05/738,173 priority patent/US4083992A/en
Publication of GB1455116A publication Critical patent/GB1455116A/en
Priority to FR7636613A priority patent/FR2333498A2/fr
Priority to DE19762655195 priority patent/DE2655195A1/de
Priority to CS771522A priority patent/CS187396B2/cs
Priority to SU772504510A priority patent/SU695555A3/ru
Priority to AT566077A priority patent/AT351557B/de
Priority to AT581577A priority patent/ATA581577A/de
Priority to US05/878,446 priority patent/US4171374A/en
Priority to US05/880,495 priority patent/US4131685A/en
Priority to US05/956,986 priority patent/US4167581A/en
Priority to KE3030A priority patent/KE3030A/xx
Priority to HK244/80A priority patent/HK24480A/xx
Priority to YU2806/80A priority patent/YU42539B/xx
Priority to MY35/81A priority patent/MY8100035A/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/14—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB4347873A 1972-12-15 1973-09-17 Pharmaceutical compositions Expired GB1455116A (en)

Priority Applications (55)

Application Number Priority Date Filing Date Title
GB4347873A GB1455116A (en) 1972-12-15 1973-09-17 Pharmaceutical compositions
IE2183/73A IE38602B1 (en) 1972-12-15 1973-12-03 Aryloxyalnolamine derivatives their preparation and use in pharmaceutical compositions
CA187,289A CA1031362A (en) 1972-12-15 1973-12-04 Alkanolamine derivatives
US421669A US3928412A (en) 1972-12-15 1973-12-04 1-Aryloxy-3-ureidoalkylamino-2-propanols
IN2664/CAL/73A IN139418B (cg-RX-API-DMAC10.html) 1972-12-15 1973-12-06
IL43795A IL43795A (en) 1972-12-15 1973-12-10 3-aminoalkylamino-1-phenoxy-2-propanol derivatives
FI3789/73A FI61027C (fi) 1972-12-15 1973-12-11 Foerfarande foer framstaellning av terapeutiskt anvaendbara alkanolaminderivat
GB5751773A GB1457876A (en) 1972-12-15 1973-12-12 Alkanolamine derivatives device for use in
SE7316863A SE408794B (sv) 1972-12-15 1973-12-13 Forfarande for framstellning av nya (fenoxi- eller naftyloxi-)propanolamin-derivat med farmakologiska egenskaper
LU68997A LU68997A1 (cg-RX-API-DMAC10.html) 1972-12-15 1973-12-13
NLAANVRAGE7317096,A NL179203C (nl) 1972-12-15 1973-12-13 Werkwijze voor het bereiden van een farmaceutisch preparaat met beta-adrenergisch blokkerende werking en werkwijze voor het bereiden van een n-gesubstitueerd 1-fenoxy-3-aminopropan-2-ol geschikt voor toepassing bij voornoemde werkwijze.
CH1340177A CH605667A5 (cg-RX-API-DMAC10.html) 1972-12-15 1973-12-14
YU3246/73A YU40097B (en) 1972-12-15 1973-12-14 Process for preparing alkanolamine derivatiaves
CH1759473A CH605666A5 (cg-RX-API-DMAC10.html) 1972-12-15 1973-12-14
FR7344780A FR2210407B1 (cg-RX-API-DMAC10.html) 1972-12-15 1973-12-14
SU7301981054A SU576917A3 (ru) 1972-12-15 1973-12-14 Способ получени производных алканоламина, их солей, рацематов или оптически -активных антиподов
AR251531A AR213930A1 (es) 1972-12-15 1973-12-14 Procedimiento para la fabricacion de nuevos derivados de 1-ariloxi-3-amidoalquilamino-2-propanol
HUIE600A HU169087B (cg-RX-API-DMAC10.html) 1972-12-15 1973-12-14
DK681673A DK158466C (da) 1972-12-15 1973-12-14 Analogifremgangsmaade til fremstilling af et alkanolaminderivat
CH1340377A CH611876A5 (en) 1972-12-15 1973-12-14 Process for the preparation of alkanolamine derivatives
NO4794/73A NO138335C (no) 1972-12-15 1973-12-14 Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
BE138894A BE808666A (fr) 1972-12-15 1973-12-14 Alkanolamines
DD175410A DD113349A5 (cg-RX-API-DMAC10.html) 1972-12-15 1973-12-14
CH1340277A CH605668A5 (cg-RX-API-DMAC10.html) 1972-12-15 1973-12-14
JP48141162A JPS5919090B2 (ja) 1972-12-15 1973-12-15 アルカノ−ルアミン誘導体及びその酸付加塩の製法
ES421538A ES421538A1 (es) 1972-12-15 1973-12-15 Procedimiento para la obtencion de derivados de alcanolami-na.
CS738727A CS187389B2 (en) 1972-12-15 1973-12-17 Method of producing alkanolamine derivatives
AT581577A AT345791B (de) 1972-12-15 1973-12-17 Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1-pheonxypropanen und von deren saeureadditionssalzen
DE2362568A DE2362568C2 (de) 1972-12-15 1973-12-17 Alkanolaminderivate und sie enthaltende pharmazeutische Zusammensetzungen
PL16765273A PL94580B1 (pl) 1973-09-17 1973-12-27 Sposob wytwarzania nowych pochodnych alkanoloaminy
SE7407702A SE417198B (sv) 1972-12-15 1974-06-11 Analogiforfarande for framstellning av alkanolaminderivat
LU71449A LU71449A1 (cg-RX-API-DMAC10.html) 1972-12-15 1974-12-10
NL7416114A NL7416114A (nl) 1972-12-15 1974-12-11 Alkanolamine derivaten en werkwijzen om hen te bereiden en toe te passen.
FR7441011A FR2254325B2 (cg-RX-API-DMAC10.html) 1972-12-15 1974-12-12
DE19742458908 DE2458908C2 (de) 1972-12-15 1974-12-12 Alkanolaminderivate und sie enthaltende pharmazeutische Zusammensetzungen
CH1657074A CH614925A5 (en) 1972-12-15 1974-12-12 Process for the preparation of alkanolamine derivatives
US05/607,995 US4010189A (en) 1972-12-15 1975-08-26 Alkanolamine derivatives
GB5003975A GB1550838A (en) 1972-12-15 1975-12-05 Alkanolamine derivatives
AT266376A AT344144B (de) 1972-12-15 1976-04-12 Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1-phenoxypropanen und von deren saeureadditionssalzen
AT266276A AT345789B (de) 1972-12-15 1976-04-12 Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1-phenoxypropanen und von deren saeureadditionssalzen
AR262359A AR214288A1 (es) 1972-12-15 1976-04-21 Procedimiento para la fabricacion de derivados 1-fenoxi-3-(ureido alquil)-amino-propanol-2
US05/738,173 US4083992A (en) 1972-12-15 1976-11-02 Alkanolamine derivatives
FR7636613A FR2333498A2 (fr) 1972-12-15 1976-12-03 Composes azotes
DE19762655195 DE2655195A1 (de) 1972-12-15 1976-12-06 Alkanolaminderivate
CS771522A CS187396B2 (en) 1972-12-15 1977-03-07 Process for preparing new derivatives of alkanolamine
SU772504510A SU695555A3 (ru) 1972-12-15 1977-07-26 Способ получени производных алканоламина ,их солей,рацематов или оптически-активных антиподов
AT566077A AT351557B (de) 1972-12-15 1977-07-29 Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1- phenoxypropanen und von deren saeureadditions- salzen
AT581577A ATA581577A (de) 1972-12-15 1977-08-09 Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1-pheonxypropanen und von deren saureadditionssalzen
US05/878,446 US4171374A (en) 1972-12-15 1978-02-16 Alkanolamine derivatives
US05/880,495 US4131685A (en) 1972-12-15 1978-02-23 Pharmaceutical compositions and uses of alkanolamine derivatives
US05/956,986 US4167581A (en) 1972-12-15 1978-11-01 Alkanolamine derivatives and pharmaceutical compositions and uses thereof
KE3030A KE3030A (en) 1972-12-15 1980-03-03 Aryloxyalkanolamine derivatives,their preparation and use in pharmaceutical compositions
HK244/80A HK24480A (en) 1972-12-15 1980-05-08 Aryloxyalkanolamine derivatives,their preparation and use in pharmaceutical compositions
YU2806/80A YU42539B (en) 1972-12-15 1980-11-03 Process for obtaining alkanolamine derivatives
MY35/81A MY8100035A (en) 1972-12-15 1981-12-30 Aryloxyalkanolamine derivatives,their preparation and use in pharmaceutical compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5797072 1972-12-15
GB4347873A GB1455116A (en) 1972-12-15 1973-09-17 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1455116A true GB1455116A (en) 1976-11-10

Family

ID=26265164

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4347873A Expired GB1455116A (en) 1972-12-15 1973-09-17 Pharmaceutical compositions

Country Status (28)

Country Link
US (2) US3928412A (cg-RX-API-DMAC10.html)
JP (1) JPS5919090B2 (cg-RX-API-DMAC10.html)
AR (2) AR213930A1 (cg-RX-API-DMAC10.html)
AT (3) AT345791B (cg-RX-API-DMAC10.html)
BE (1) BE808666A (cg-RX-API-DMAC10.html)
CA (1) CA1031362A (cg-RX-API-DMAC10.html)
CH (4) CH605666A5 (cg-RX-API-DMAC10.html)
CS (1) CS187389B2 (cg-RX-API-DMAC10.html)
DD (1) DD113349A5 (cg-RX-API-DMAC10.html)
DE (1) DE2362568C2 (cg-RX-API-DMAC10.html)
DK (1) DK158466C (cg-RX-API-DMAC10.html)
ES (1) ES421538A1 (cg-RX-API-DMAC10.html)
FI (1) FI61027C (cg-RX-API-DMAC10.html)
FR (1) FR2210407B1 (cg-RX-API-DMAC10.html)
GB (1) GB1455116A (cg-RX-API-DMAC10.html)
HK (1) HK24480A (cg-RX-API-DMAC10.html)
HU (1) HU169087B (cg-RX-API-DMAC10.html)
IE (1) IE38602B1 (cg-RX-API-DMAC10.html)
IL (1) IL43795A (cg-RX-API-DMAC10.html)
IN (1) IN139418B (cg-RX-API-DMAC10.html)
KE (1) KE3030A (cg-RX-API-DMAC10.html)
LU (1) LU68997A1 (cg-RX-API-DMAC10.html)
MY (1) MY8100035A (cg-RX-API-DMAC10.html)
NL (1) NL179203C (cg-RX-API-DMAC10.html)
NO (1) NO138335C (cg-RX-API-DMAC10.html)
SE (1) SE408794B (cg-RX-API-DMAC10.html)
SU (2) SU576917A3 (cg-RX-API-DMAC10.html)
YU (2) YU40097B (cg-RX-API-DMAC10.html)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2822473A1 (de) * 1977-05-23 1978-12-14 Ici Ltd Alkanolaminderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
US4172150A (en) * 1977-05-23 1979-10-23 Imperial Chemical Industries Limited Cardiac stimulants
EP0207036A1 (en) * 1985-06-20 1986-12-30 Aktiebolaget Hässle New para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylamino-propanol-2-s having beta receptor blocking properties.
US4636501A (en) * 1981-12-17 1987-01-13 Aktiebolaget Hassle Para-substituted 3-phenoxy-1-carbonylamino-alkylamino-propanol compounds, beta receptor blocking compositions and use
GB2188234A (en) * 1986-03-25 1987-09-30 Ici Plc Obesity treating agents
GB2188235A (en) * 1986-03-25 1987-09-30 Ici Plc Topical anti-inflammatory compositions

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US4167581A (en) * 1972-12-15 1979-09-11 Imperial Chemical Industries Limited Alkanolamine derivatives and pharmaceutical compositions and uses thereof
US4171374A (en) * 1972-12-15 1979-10-16 Imperial Chemical Industries Limited Alkanolamine derivatives
US4117157A (en) * 1973-06-22 1978-09-26 Imperial Chemical Industries Limited Ethanolamine derivatives having β-adrenergic blocking activity
US4034112A (en) * 1973-06-22 1977-07-05 Imperial Chemical Industries Limited Ethanolamine derivatives having β-adrenergic blocking activity
US4041074A (en) * 1973-07-19 1977-08-09 Imperial Chemical Industries Limited 1-Hydroxyaryl-2-amidoalkylaminoethanol derivatives
GB1573359A (en) * 1977-12-20 1980-08-20 Ici Ltd Alkanolamine derivatives
GB1509527A (en) * 1974-06-05 1978-05-04 Ici Ltd 1-(aryl-or heteroaryl)oxy-3-(substituted-amino)propan-2-ol derivatives processes for their manufacture and pharmaceutical compositions containing them
US4041075A (en) * 1973-12-12 1977-08-09 Imperial Chemical Industries Limited Phenoxy-alkanolamine derivatives
AT334385B (de) * 1973-12-20 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
US4141987A (en) * 1974-06-05 1979-02-27 Imperial Chemical Industries Limited 1-Aryloxy-3-thenamidoalkylamino-2-propanol derivatives
US4162331A (en) * 1975-06-17 1979-07-24 Nippon Shinyaku Co., Ltd. Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives
GB1540463A (en) * 1976-10-07 1979-02-14 Ici Ltd Alkanolamine derivatives
US4219561A (en) * 1977-09-22 1980-08-26 Imperial Chemical Industries Limited Alkanolamine derivatives
US4239700A (en) * 1978-10-10 1980-12-16 Texaco Development Corp. Isatoic anhydride derivatives and use as chain-extenders
US4281189A (en) * 1979-09-06 1981-07-28 Hoffmann-La Roche Inc. Sulfonamide intermediates for adrenergic blocking agents
US4301300A (en) * 1979-09-06 1981-11-17 Hoffmann-La Roche Inc. Sulfonamide intermediates for adrenergic blocking agents
FR2477537A1 (fr) * 1980-03-07 1981-09-11 Francaise Sucrerie Nouvelles guanidines acylees, urees et urees substituees, leur procede de fabrication et leur application en tant que medicaments
FI76551C (fi) 1980-11-06 1988-11-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.
US5238962A (en) * 1983-03-03 1993-08-24 Hoffmann-La Roche Inc. Benzamide derivatives
CH653670A5 (de) * 1983-03-03 1986-01-15 Hoffmann La Roche Benzamid-derivate.
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
DE3427309A1 (de) * 1984-07-25 1986-01-30 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-aryloxypropanolamine, verfahren zu ihrer herstellung und ihre verwendung
DE3512627A1 (de) * 1985-04-06 1986-10-09 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel
IL78783A (en) * 1985-05-14 1990-08-31 Louis William John 3-phenoxypropanolamine derivatives,their preparation and pharmaceutical compositions containing them
JPH0228141A (ja) * 1987-11-13 1990-01-30 Glaxo Group Ltd フェネタノールアミン誘導体
JP2004137284A (ja) * 1997-06-17 2004-05-13 Kaken Pharmaceut Co Ltd ２−スルファモイル安息香酸誘導体
GB0417802D0 (en) * 2004-08-10 2004-09-15 Novartis Ag Organic compounds
CN106977426A (zh) * 2017-05-27 2017-07-25 哈尔滨师范大学 一种腰果酚苯基脲及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes
GB1199037A (en) * 1967-09-27 1970-07-15 Ici Ltd Alkanolamine Derivatives
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
BE754604A (fr) * 1969-08-08 1971-02-08 Boehringer Sohn Ingelheim Le 1-(2-nitrilophenoxy)-2-hydroxy-3-ethyl-aminopropane et ses sels

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2822473A1 (de) * 1977-05-23 1978-12-14 Ici Ltd Alkanolaminderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
FR2391997A1 (fr) * 1977-05-23 1978-12-22 Ici Ltd Nouveaux derives d'alcanolamines, leur procede de preparation et composition pharmaceutique les contenant
US4143140A (en) * 1977-05-23 1979-03-06 Imperial Chemical Industries Limited Morpholine carboxamides and use thereof
US4172150A (en) * 1977-05-23 1979-10-23 Imperial Chemical Industries Limited Cardiac stimulants
US4636501A (en) * 1981-12-17 1987-01-13 Aktiebolaget Hassle Para-substituted 3-phenoxy-1-carbonylamino-alkylamino-propanol compounds, beta receptor blocking compositions and use
EP0207036A1 (en) * 1985-06-20 1986-12-30 Aktiebolaget Hässle New para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylamino-propanol-2-s having beta receptor blocking properties.
GB2188234A (en) * 1986-03-25 1987-09-30 Ici Plc Obesity treating agents
GB2188235A (en) * 1986-03-25 1987-09-30 Ici Plc Topical anti-inflammatory compositions
EP0244937A3 (en) * 1986-03-25 1988-07-20 Imperial Chemical Industries Plc Pharmaceutical compositions containing (R,S) or (S) N-(2-[2-hydroxy-3-phenoxypropyl]aminoethyl)isobutyramide
EP0244080A3 (en) * 1986-03-25 1990-05-16 Imperial Chemical Industries Plc Medicament for the treatment of obesity
US4937267A (en) * 1986-03-25 1990-06-26 Imperial Chemical Industries Plc Method of treatment of obesity
GB2188235B (en) * 1986-03-25 1990-11-14 Ici Plc Pharmaceutical compositions
GB2188234B (en) * 1986-03-25 1991-01-02 Ici Plc Therapeutic agents

Also Published As

Publication number Publication date
NL7317096A (cg-RX-API-DMAC10.html) 1974-06-18
FI61027B (fi) 1982-01-29
IE38602L (en) 1974-06-15
YU324673A (en) 1982-02-28
CH611876A5 (en) 1979-06-29
JPS5919090B2 (ja) 1984-05-02
DK158466C (da) 1990-10-15
US4010189A (en) 1977-03-01
HK24480A (en) 1980-05-16
IN139418B (cg-RX-API-DMAC10.html) 1976-06-19
DK158466B (da) 1990-05-21
AR213930A1 (es) 1979-04-11
BE808666A (fr) 1974-06-14
AT345791B (de) 1978-10-10
YU42539B (en) 1988-10-31
MY8100035A (en) 1981-12-31
ATA566077A (de) 1979-01-15
IL43795A0 (en) 1974-03-14
YU280680A (en) 1983-09-30
LU68997A1 (cg-RX-API-DMAC10.html) 1974-02-22
HU169087B (cg-RX-API-DMAC10.html) 1976-09-28
ES421538A1 (es) 1976-07-16
DD113349A5 (cg-RX-API-DMAC10.html) 1975-06-05
DE2362568A1 (de) 1974-06-20
NO138335C (no) 1978-08-16
SE408794B (sv) 1979-07-09
FR2210407B1 (cg-RX-API-DMAC10.html) 1978-01-13
ATA266376A (de) 1977-11-15
AT344144B (de) 1978-07-10
NL179203C (nl) 1986-08-01
CA1031362A (en) 1978-05-16
YU40097B (en) 1985-08-31
CH605668A5 (cg-RX-API-DMAC10.html) 1978-10-13
AR214288A1 (es) 1979-05-31
KE3030A (en) 1980-03-14
SU695555A3 (ru) 1979-10-30
IL43795A (en) 1978-03-10
NO138335B (no) 1978-05-08
FR2210407A1 (cg-RX-API-DMAC10.html) 1974-07-12
IE38602B1 (en) 1978-04-26
JPS4994638A (cg-RX-API-DMAC10.html) 1974-09-09
CS187389B2 (en) 1979-01-31
NL179203B (nl) 1986-03-03
SU576917A3 (ru) 1977-10-15
CH605666A5 (cg-RX-API-DMAC10.html) 1978-10-13
CH605667A5 (cg-RX-API-DMAC10.html) 1978-10-13
US3928412A (en) 1975-12-23
DE2362568C2 (de) 1983-11-03
FI61027C (fi) 1982-05-10
AT351557B (de) 1979-08-10

Similar Documents

Publication Publication Date Title
GB1455116A (en) Pharmaceutical compositions
IE32739L (en) Alkanolamines
GB1460593A (en) Ethanolamine derivatives
GB1285038A (en) Alkanolamine derivatives
FR2469178A1 (fr) Solution aqueuse de nitroglycerine et composition pharmaceutique renfermant cette solution
ES357931A2 (es) Procedimiento para la fabricacion de derivados de alcanola-mina.
GB1269775A (en) Alkanolamine derivatives
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
ES8107174A1 (es) Procedimiento para la preparacion de nuevos derivados de urea
ATE69228T1 (de) Amidabkoemmlinge.
IE36331L (en) Phenoxyalkanolamine derivatives
GB1465025A (en) Substituted phenylisothioureas a process for their preparation and their use as medicaments
GB1269781A (en) Alkanolamine derivatives
GB1396322A (en) Alkanolamine derivatives
GB1312555A (en) Alkanolamine derivatives
GB1392610A (en) Alkanolamine derivatives
GB1270723A (en) Alkanolamine derivatives
GB1414781A (en) Alkanolamine derivatives
MY100752A (en) Pharmaceutical composition for combating malaria.
GB1287497A (en) Basic ether compositions
GB1095220A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
ATE26271T1 (de) Benzhydrylpiperazine-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB1312055A (en) Alkanolamine derivatives
FR2469924A1 (fr) Composition pharmaceutique injectable a action prolongee, contenant comme agents actifs du sulfamethoxazole et de la trimethoprime, et son procede de preparation
JPS5247917A (en) Herbicides

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years

Effective date: 19931129